It has been reported that PADI4 can promote the invasion and migration of osteosarcoma cells through EMT (Zhai et al. 2020), and anti-PADI4 inhibits the EMT of breast cancer cells by inhibiting the expression of PADI4 in the cell membrane. This evidence concerns the gene PADI4 and breast cancer.